ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CLEMENTE ZULUETA MD

Endocrinology, Diabetes Metabolism

15,741

$881K

485
199 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

46%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 46%

$56
Average prescription price

Avg: $123

JAHANGIR CYRUS M.D.

Endocrinology, Diabetes Metabolism

13,600

$2.12M

637
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 46%

$156
Average prescription price

Avg: $123

HAZEL YANG M.D.

Endocrinology, Diabetes Metabolism

13,509

$1.68M

731
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 46%

$124
Average prescription price

Avg: $123

ROGELIO UY M.D.

Endocrinology, Diabetes Metabolism

12,661

$948K

360
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

22%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 46%

$75
Average prescription price

Avg: $123

GLEN VAN LOON MD PH.D.

Endocrinology, Diabetes Metabolism

12,065

$904K

468
349 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 46%

$75
Average prescription price

Avg: $123

WENDELL MIERS M.D.

Endocrinology, Diabetes Metabolism

9,673

$1.59M

739
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$165
Average prescription price

Avg: $123

HISHAM ALREFAI MD

Endocrinology, Diabetes Metabolism

9,549

$1.78M

578
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 46%

$187
Average prescription price

Avg: $123

GEORGE BORST M.D.

Endocrinology, Diabetes Metabolism

9,229

$814K

724
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 46%

$88
Average prescription price

Avg: $123

LYLE MYERS M.D.

Endocrinology, Diabetes Metabolism

9,066

$1.27M

730
515 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 46%

$140
Average prescription price

Avg: $123

DAVID SHADOWEN M.D.

Endocrinology, Diabetes Metabolism

8,673

$1.12M

476
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 46%

$129
Average prescription price

Avg: $123

RALPH HINES MD

Endocrinology, Diabetes Metabolism

8,440

$698K

301
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 46%

$83
Average prescription price

Avg: $123

DONALD WOOD MD

Endocrinology, Diabetes Metabolism

7,765

$1.19M

574
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 46%

$153
Average prescription price

Avg: $123

KRISTINA HUMPHRIES MD

Endocrinology, Diabetes Metabolism

7,271

$587K

369
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 46%

$81
Average prescription price

Avg: $123

LAL TANWANI M.D.

Endocrinology, Diabetes Metabolism

7,079

$1.13M

612
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$159
Average prescription price

Avg: $123

MOUSSA ALHAJ M.D.

Endocrinology, Diabetes Metabolism

6,852

$890K

478
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$130
Average prescription price

Avg: $123

ZOUHAIR BIBI MD

Endocrinology, Diabetes Metabolism

6,483

$849K

531
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 46%

$131
Average prescription price

Avg: $123

YANCEY HOLMES M.D.

Endocrinology, Diabetes Metabolism

6,163

$1.01M

536
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 46%

$164
Average prescription price

Avg: $123

ANGELINO YSON MD

Endocrinology, Diabetes Metabolism

5,875

$580K

353
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 46%

$99
Average prescription price

Avg: $123

NGUYEN YOUNG MD

Endocrinology, Diabetes Metabolism

5,855

$544K

388
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 46%

$93
Average prescription price

Avg: $123

CHARLES HOFFMAN M.D.

Endocrinology, Diabetes Metabolism

5,739

$1.15M

533
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 46%

$200
Average prescription price

Avg: $123

JAMAL MERHY M.D.

Endocrinology, Diabetes Metabolism

5,155

$518K

255
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 46%

$100
Average prescription price

Avg: $123

BRADLEY EILERMAN MD

Endocrinology, Diabetes Metabolism

4,950

$874K

449
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 46%

$176
Average prescription price

Avg: $123

KAILASH SABHARWAL MD

Endocrinology, Diabetes Metabolism

4,673

$347K

222
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 46%

$74
Average prescription price

Avg: $123

FRED WILLIAMS M.D.

Endocrinology, Diabetes Metabolism

4,516

$654K

364
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$145
Average prescription price

Avg: $123

OMOLARA FAKUNLE M.D.

Endocrinology, Diabetes Metabolism

4,395

$561K

346
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$128
Average prescription price

Avg: $123

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank